Full-Time

Senior Medical Director

Medical Affairs Strategy, Oncology

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Biotechnology
Healthcare

Compensation Overview

$230k - $260kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • MD degree and 10+ years broad bio/pharmaceutical industry experience in a pharmaceutical/biotech setting
  • 5+ years of proven Medical Affairs leadership, building and implementing a successful Medical Affairs strategy and infrastructure
  • Strong analytical and problem-solving skills, with an ability to evaluate scientific data and medical literature and the ability to extrapolate to medical, marketing, or sales programs required
  • Understanding of the US Healthcare system, the pharmaceutical industry, and clinical and health economic practices in the US is required
  • Strong oral, written, and presentation skills with a thorough understanding of current medical oncology practice and the willingness to learn new areas of oncology
  • The successful candidate must thrive working in a fast-paced, innovative environment while remaining flexible, proactive, resourceful and efficient in that setting. Must excel in a multidisciplinary environment as an integral leader and provide medical science leadership within assigned teams. Ability to analyze complex issues to develop relevant and realistic plans, programs and recommendations is essential.
  • Excellent and impactful written and verbal communication skills, strong problem-solving ability, and self-motivated. A hands-on approach to performing duties with a strong self-directed work ethic and attention to detail and quality are critical to success
  • Executive presence; confident, positive attitude, and enthusiastic.
  • Knowledge of multiple therapeutic areas related to Coherus immune-oncology portfolio, as well as proficient experience in oncology and immuno-oncology. Internal medicine and oncology experience/training is preferred.
  • Extensive and recent product launch experience in oncology, having successfully launched key products/brands preferred.
  • Broad working knowledge of FDA requirements, industry compliance.
  • Experience with US market medical promotional review preferred.
  • Effective presentation skills to key stakeholders and key decision makers.
  • Strong negotiation skills, and must be able to solicit information, persuade others and reach outcomes for overall strategic plan.
Responsibilities
  • Lead the development and implement the Medical Affairs strategic plan across Coherus’ immuno-oncology portfolio (marketed and investigational products). Measure and assess the effectiveness of the US Medical plans regularly
  • Medical Affairs product lifecycle management (including real world evidence strategy) and launch readiness plans
  • Lead development and execution of competitive intelligence plan and deliverables
  • Develop Investigator Initiated Trials (IIT) strategy including areas of interest and budget. Oversee and serve as Chair and coordinator/administrator of the IIT program, consistently engage with HCPs to understand their evolving medical needs, identify knowledge gaps, and evolve IIT research areas of interest
  • Oversee the CME program and serve as the CME program coordinator
  • Provide medical expertise and approval of US promotional materials
  • Provide medical expertise and approval (if applicable) of non-promotional materials including but not limited to data analytics
  • Review and approve all standard and custom Medical Information response letters
  • Lead advisory boards in collaboration with Clinical Development to drive input for lifecycle management, HCP education etc.
  • Serve as member of the Product Development Team(s)
  • Cultivate relationships with diverse external audience including but not limited to medical and scientific experts, clinical researchers, academic institutions, community oncology, and research consortia, to assess unmet medical needs to develop and execute appropriate medical strategy
  • Serve as medical expert presenter and educator for internal and external needs (advisory boards, round tables, promotional speaker training, investigator meetings, congress presentation, etc.)
  • Contribute to medical communications by authorizing and/or reviewing abstracts, presentations and manuscripts for medical accuracy and content
  • Participate in medical and cross-functional strategy meetings and provide medical expertise including the safety review team
  • Assess, develop, and execute research collaborations across Coherus portfolio products
  • Oversee and execute Medical Affairs sponsored clinical studies including development and review of study protocols
  • Develop, refine and implement all required Medical Affairs policies, procedures and SOPs
  • Provide Medical expertise to the Commercial organization in a compliant manner as needed to assist in the development and execution of commercial activities
  • Provide medical expertise and input for new product licensing and acquisition opportunities and study protocols for clinical collaborations
  • Represent Coherus at key medical conferences and external events
  • Foster a culture of 100% compliance

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on research, development, and commercialization of these products, ensuring they meet strict regulatory standards for quality and efficacy. Coherus aims to improve patient lives by expanding access to essential biologic treatments, helping to offset rising healthcare costs. Their business model allows them to generate revenue through the sale of these cost-effective alternatives, giving them a competitive advantage in the biopharmaceutical market.

Company Stage

IPO

Total Funding

$114.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-8%

1 year growth

-13%

2 year growth

-20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Global biosimilars market projected to grow at 24.7% CAGR from 2023 to 2030.
  • FDA guidance on biosimilar interchangeability enhances market acceptance and adoption.
  • Partnerships with research institutes expand treatment options and clinical trial advancements.

What critics are saying

  • Increased competition from Sandoz may impact market share and pricing strategies.
  • 30% staff reduction could lead to operational challenges and pipeline management issues.
  • Divestment of Canadian rights to Toripalimab may limit market presence in Canada.

What makes Coherus BioSciences unique

  • Coherus focuses on cost-effective biosimilars for oncology and inflammatory diseases.
  • The company emphasizes high-quality biologic therapeutics with rigorous regulatory approval.
  • Coherus collaborates with research institutes for novel drug combinations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA